Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,684 | -22,001 | -14,777 | -9,492 | -6,735 |
| Depreciation Amortization | 863 | 4,100 | 3,067 | 2,026 | 1,009 |
| Income taxes - deferred | N/A | -92 | N/A | N/A | N/A |
| Accounts receivable | -867 | 2,610 | 594 | 337 | 3,090 |
| Accounts payable and accrued liabilities | -992 | 644 | 98 | 572 | -1,053 |
| Other Working Capital | -1,198 | 331 | -3,012 | -1,773 | 522 |
| Other Operating Activity | 4,830 | 1,534 | 2,863 | 1,337 | -1,002 |
| Operating Cash Flow | $-5,048 | $-12,874 | $-11,167 | $-6,993 | $-4,169 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -91 | -238 | -234 | -167 | -57 |
| Investing Cash Flow | $-91 | $-238 | $-234 | $-167 | $-57 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 40,000 | N/A | 0 | 0 | 0 |
| Debt Repayment | -35,083 | -182 | -110 | -73 | -38 |
| Common Stock Issued | 2 | 6,085 | 6,043 | 3,042 | 0 |
| Other Financing Activity | -3,686 | -183 | -183 | -108 | 0 |
| Financing Cash Flow | $1,233 | $5,720 | $5,750 | $2,861 | $-38 |
| Exchange Rate Effect | 93 | 483 | 299 | 204 | 22 |
| Beginning Cash Position | 24,101 | 31,010 | 31,010 | 31,010 | 31,010 |
| End Cash Position | 20,288 | 24,101 | 25,658 | 26,915 | 26,768 |
| Net Cash Flow | $-3,813 | $-6,909 | $-5,352 | $-4,095 | $-4,242 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,048 | -12,874 | -11,167 | -6,993 | -4,169 |
| Capital Expenditure | -91 | -238 | -234 | -167 | -57 |
| Free Cash Flow | -5,139 | -13,112 | -11,401 | -7,160 | -4,226 |